Fig. 3From: Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim®) in the treatment of uncomplicated malaria at public health facilities in four African countriesSymptoms presented by participants on unscheduled visitsBack to article page